What is the Barbeau Test?
The Barbeau test is a preprocedural assessment that uses pulse oximetry to evaluate collateral hand circulation by monitoring the plethysmographic waveform on the thumb or index finger while compressing the radial artery, though current guidelines indicate it is only of historical interest and should not be routinely performed or used to exclude patients from transradial access 1.
How the Test Works
The Barbeau test evaluates palmar arch patency by placing a pulse oximeter on the thumb or index finger and observing the plethysmographic waveform while compressing the radial artery. The test classifies results into four waveform patterns (A through D), with type D indicating absent collateral flow from the ulnar artery.
Current Clinical Relevance
Routine application of the Barbeau test is not recommended and an abnormal test should not preclude transradial access 1. The 2018 American Heart Association scientific statement explicitly states that performing the Barbeau test (or Allen test) to confirm dual arterial circulation is "only of historical interest" 1.
Key Evidence Supporting Non-Use:
- Recent studies of patients with both normal and abnormal preprocedural tests showed no differences in thumb capillary lactate, grip strength, or incidence of hand ischemia between groups 1
- The test does not serve as a useful triage strategy for patient selection 1
The Reverse Barbeau Test (Different Application)
While the preprocedural Barbeau test is obsolete, the reverse Barbeau test (RBT) has emerged as a useful post-procedural tool for detecting radial artery occlusion (RAO). The RBT evaluates radial artery patency by monitoring the radial oximetry waveform during ulnar artery compression 2, 3.
Post-Procedural Detection Performance:
- The RBT correctly identifies radial artery patency with high accuracy 2, 3
- In a 2020 study of 500 patients, the RBT detected all cases of complete RAO with 99.0% patency confirmation, comparable to duplex ultrasonography 3
- Important caveat: The RBT may overestimate radial occlusion, identifying some cases as occluded that ultrasound confirms as patent 4
- A 2021 study found the RBT overestimated occlusion in 28% of cases preprocedurally and 60% at 24 hours compared to ultrasound 4
Clinical Bottom Line
- Do not perform the preprocedural Barbeau test - it provides no clinical benefit and should not influence access site selection 1
- Consider using the reverse Barbeau test post-procedurally as a simple screening tool for RAO, though duplex ultrasonography remains the gold standard 2, 3
- The reverse Barbeau test's simplicity makes it practical for routine post-procedural assessment, though be aware it may overestimate occlusion 4, 3